RGC Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 22:00):

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder...

Stats
Tagesvolumen	5 027.00
Durchschnittsvolumen	4 224.00
Marktkapitalisierung	60.51M
EPS	$0 ( 2024-01-26 )
Last Dividend	$0.220 ( 2018-02-15 )
Next Dividend	$0 ( N/A )
P/E	-10.33
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2018-02-28	Anschutz Philip F	Sell	12 440 000	CLASS A COMMON STOCK
2018-02-28	Anschutz Philip F	Sell	23 708 639	CLASS B COMMON STOCK
2018-02-28	Campbell Michael L	Sell	703 660	Class A Common Stock
2018-02-28	Yemenidjian Alex	Sell	21 880	Class A Common Stock
2018-02-28	Tyrrell Jack	Sell	136 684	Class A Common Stock

INSIDER POWER
0.00
Last 97 transactions
Buy: 583 544 \| Sell: 71 137 085

Regencell Bioscience Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Regencell Bioscience Finanzdaten

Annual	2023
Umsatz:	$0
Bruttogewinn:	$-769 687 (0.00 %)
EPS:	$-0.450

FY	2023
Umsatz:	$0
Bruttogewinn:	$-769 687 (0.00 %)
EPS:	$-0.450

FY	2022
Umsatz:	$0
Bruttogewinn:	$-604 397 (0.00 %)
EPS:	$-0.570

FY	2021
Umsatz:	$0.00
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-0.107

Financial Reports:

No articles found.

Regencell Bioscience Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Regencell Bioscience Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$0.180	2009-06-02
Last Dividend	$0.220	2018-02-15
Next Dividend	$0	N/A
Payout Date	2018-02-26
Next Payout Date	N/A
# dividends	36	--
Total Paid Out	$7.52	--
Avg. Dividend % Per Year	0.00%	--
Score	1.86	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-06-24)

$0 Estimate 0.00 %

Dividend Stability

0.13 Bad

Dividend Score

1.86

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	-0.465	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.660	1.500	-8.44	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	19.15	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	19.15	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.58	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0367	-1.500	9.39	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.118	2.00	9.96	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.118	2.00	9.94	10.00	[0 - 20]
debtEquityRatioTTM	0.0385	-1.500	9.85	-10.00	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	3.32	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.59

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-11.86	1.000	-1.299	0	[1 - 100]
returnOnEquityTTM	-0.660	2.50	-5.43	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.118	2.00	9.96	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.118	2.00	9.96	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-1.056	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-0.380

Regencell Bioscience